Park Geo-Seong, Choi Ha-Young, Jang Hyoung-Gyu, Park Jung-Soo, Koh Eun-Jeong, Lee Jong-Myeong
Department of neurosurgery Jeonbuk National University Hospital, Jeonju, Korea.
J Cerebrovasc Endovasc Neurosurg. 2022 Jun;24(2):113-120. doi: 10.7461/jcen.2021.E2021.08.003. Epub 2021 Oct 14.
Adrenocorticotropic hormone (ACTH) and β-endorphin are pituitary neuro-peptides released by acute stress. We determined why the prognosis of patients with subarachnoid hemorrhages (SAH) due to aneurysmal rupture is not always dependent on the Hunt-Hess grading system (HHS) and delta-National Institutes of Health Stroke Scale (NIHSS), while studying endogenous neuropeptides, including ACTH and β-endorphin.
We analyzed blood samples collected from patients with SAH (SAH group; n=37) and those with unruptured intracranial aneurysms (control group; n=37). Blood sampling was performed before any procedure or chemical agents administration. The results of ACTH and β-endorphin measurements were compared using the delta-NIHSS and HHS. The data were analyzed using descriptive statistics, independent samples t-tests, and Pearson's correlations.
Of the 18 patients with low-grade HHS, 13 had low delta-NIHSS and five showed high delta-NIHSS. Of the 19 patients with high-grade HHS, the delta-NIHSS was ≥14 in the other five patients. ACTH concentration was high (497.3 pg/mL) in five patients with high-grade HHS and high delta-NIHSS. β-endorphin concentration was high (159.7 pg/mL) in 13 patients with low-grade HHS and low delta-NIHSS.
High ACTH levels in patients with massive bleeding and poor neurological status suggests increasing ACTH secretion in response to bleeding stress, which may aggravate neurological status. Contrary to ACTH, high β-endorphin levels in patients with low-grade HHS implied the involvement of additional factors in predicting fair outcomes related to low delta-NIHSS. These results may provide insight into the varying prognostic potential of HHS in SAH patients.
促肾上腺皮质激素(ACTH)和β-内啡肽是急性应激时释放的垂体神经肽。我们在研究包括ACTH和β-内啡肽在内的内源性神经肽时,确定了为什么动脉瘤破裂所致蛛网膜下腔出血(SAH)患者的预后并不总是依赖于Hunt-Hess分级系统(HHS)和差值美国国立卫生研究院卒中量表(NIHSS)。
我们分析了从SAH患者(SAH组;n = 37)和未破裂颅内动脉瘤患者(对照组;n = 37)采集的血样。在进行任何操作或给予化学药物之前进行血样采集。使用差值NIHSS和HHS比较ACTH和β-内啡肽的测量结果。使用描述性统计、独立样本t检验和Pearson相关性分析数据。
在18例低分级HHS患者中,13例差值NIHSS低,5例差值NIHSS高。在19例高分级HHS患者中,另外5例差值NIHSS≥14。5例高分级HHS且差值NIHSS高的患者ACTH浓度高(497.3 pg/mL)。13例低分级HHS且差值NIHSS低的患者β-内啡肽浓度高(159.7 pg/mL)。
大出血且神经功能状态差的患者ACTH水平高表明其对出血应激反应中ACTH分泌增加,这可能会加重神经功能状态。与ACTH相反,低分级HHS患者β-内啡肽水平高意味着在预测与低差值NIHSS相关的良好预后方面存在其他因素。这些结果可能有助于深入了解HHS在SAH患者中不同的预后潜力。